EP4309570A1 — Systems and methods for monitoring and managing life of a battery in an analyte sensor system worn by a user
Assigned to Dexcom Inc · Expires 2024-01-24 · 2y expired
What this patent protects
Systems and methods for analyte monitoring, particularly systems and methods for monitoring and managing life of a battery in an analyte sensor system worn by a user, are provided. Disclosed is an analyte sensor system configured to be worn by a user, comprising: an analyte senso…
USPTO Abstract
Systems and methods for analyte monitoring, particularly systems and methods for monitoring and managing life of a battery in an analyte sensor system worn by a user, are provided. Disclosed is an analyte sensor system configured to be worn by a user, comprising: an analyte sensor (312); a transceiver (316) configured to transmit and receive wireless signals; a battery (330); a battery measurement module (340) coupled to the battery and configured to measure a value indicative of a current power level of the battery; a prediction module (356) coupled to the battery measurement module and configured to predict remaining useful lite of the battery based on the measured value and an assumed future usage of the analyte sensor system; and a control module (354) coupled to the transceiver and at least one of the battery measurement module and the prediction module and configured to control one or more data transmission functions of the analyte sensor system based on at feast one of the measured value and the predicted remaining useful life.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.